Operating Lease, Right-of-Use Asset of Tango Therapeutics, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Tango Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Tango Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $35,624,000, a 9.8% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Tango Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $35,624,000 -$3,852,000 -9.8% 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q3 2025 $36,582,000 -$3,848,000 -9.5% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $37,555,000 -$3,816,000 -9.2% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $39,697,000 -$2,389,000 -5.7% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $39,476,000 -$4,032,000 -9.3% 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q3 2024 $40,430,000 -$3,992,000 -9% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $41,371,000 -$3,954,000 -8.7% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $42,086,000 -$4,139,000 -9% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $43,508,000 -$3,378,000 -7.2% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $44,422,000 -$3,335,000 -7% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $45,325,000 +$44,805,000 +8616% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $46,225,000 +$45,331,000 +5071% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $46,886,000 +$45,632,000 +3639% 31 Dec 2022 10-K 18 Mar 2024 2023 FY
Q3 2022 $47,757,000 +$41,025,000 +609% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $520,000 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 $894,000 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 $1,254,000 -$6,226,000 -83% 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q3 2021 $6,732,000 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q4 2020 $7,480,000 31 Dec 2020 10-K 28 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.